Medicare Enrolled
Dr. Horacio Capote, M.D.
Psychiatry · Amherst, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Capote from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Capote?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Capote
Dr. Horacio Capote is a psychiatry specialist in Amherst, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Capote performed 975 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Capote received a total of $990,973 from 56 pharmaceutical and/or device companies across 2398 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Capote is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 13% volume in NY
$990,973 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗975
Medicare services
Top 13% in NY for psychiatry
Not available
Unique patients (not deduplicated)
$221
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
222 | $3 | $8 |
| Office visit with esketamine nasal spray administration An office visit for an established patient that includes physician supervision and the administration of more than 56 mg of esketamine nasal spray. |
203 | $888 | $1,700 |
| Psychiatric diagnostic evaluation with medical services A psychiatric assessment that includes medical services to evaluate mental health conditions. |
122 | $131 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $76 | $150 |
| Psychiatric services complicated by communication factor Psychiatric evaluation or treatment provided when communication barriers complicate the interaction between the provider and the patient. |
76 | $11 | $23 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
64 | $11 | $40 |
| Psychotherapy and evaluation, 30 minutes A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes. |
46 | $49 | $90 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
35 | $0 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $43 | $100 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
27 | $96 | $220 |
| 45-minute psychotherapy and evaluation visit A 45-minute session that includes both psychotherapy and an evaluation and management visit. |
24 | $57 | $125 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $49 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.2% high complexity
6.6% medium
85.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$990,973
Total received (2018-2024)
Avg $141,568/year across 7 years
Top 0% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
2,398
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$249,827
2023
$130,033
2022
$121,551
2021
$65,176
2020
$52,294
2019
$204,585
2018
$167,507
Payments by company (2024)
Otsuka America Pharmaceutical, Inc.
$91,229
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$85,793
Janssen Pharmaceuticals, Inc
$42,060
Axsome Therapeutics, Inc.
$12,271
Teva Pharmaceuticals USA, Inc.
$8,507
ABBVIE INC.
$5,252
Indivior Inc.
$2,818
Supernus Pharmaceuticals, Inc.
$509
Neurocrine Biosciences, Inc.
$228
Alkermes, Inc.
$202
Vanda Pharmaceuticals Inc.
$186
Lundbeck LLC
$174
E.R. Squibb & Sons, L.L.C.
$134
LivaNova USA, Inc.
$122
Biogen, Inc.
$84
IDORSIA PHARMACEUTICALS US INC
$80
HARMONY BIOSCIENCES LLC
$49
Otsuka Pharmaceutical Development & Commercialization, Inc.
$31
Azurity Pharmaceuticals, Inc.
$22
Noven Therapeutics, LLC
$20
Janssen Scientific Affairs, LLC
$19
Orexo US, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Top 3 companies account for 87.7% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$200,462
Janssen Pharmaceuticals, Inc
$198,004
ACADIA Pharmaceuticals Inc
$188,365
Sunovion Pharmaceuticals Inc.
$90,700
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$85,793
Teva Pharmaceuticals USA, Inc.
$77,176
ITI, Inc.
$75,862
Axsome Therapeutics, Inc.
$23,848
US WorldMeds, LLC
$10,767
ABBVIE INC.
$9,503
AbbVie Inc.
$7,472
Merck Sharp & Dohme Corporation
$3,758
Indivior Inc.
$3,071
Janssen Scientific Affairs, LLC
$1,992
JAZZ PHARMACEUTICALS INC.
$1,955
Lundbeck LLC
$1,747
Alkermes, Inc.
$1,681
IDORSIA PHARMACEUTICALS US INC
$1,568
Vanda Pharmaceuticals Inc.
$1,113
Neurocrine Biosciences, Inc.
$849
Supernus Pharmaceuticals, Inc.
$769
Avanir Pharmaceuticals, Inc.
$731
Allergan Inc.
$558
Takeda Pharmaceuticals U.S.A., Inc.
$509
Amgen Inc.
$250
Biogen, Inc.
$211
Bausch Health US, LLC
$203
ARBOR PHARMACEUTICALS, INC.
$186
Corium, LLC
$179
LivaNova USA, Inc.
$177
Otsuka Pharmaceutical Development & Commercialization, Inc.
$160
Biohaven Pharmaceuticals, Inc.
$144
E.R. Squibb & Sons, L.L.C.
$134
Arbor Pharmaceuticals, Inc.
$117
EISAI INC.
$100
Orexo US, Inc.
$95
Horizon Therapeutics plc
$93
Azurity Pharmaceuticals, Inc.
$83
Abbott Laboratories
$82
Eisai Inc.
$78
Merck Sharp & Dohme LLC
$60
HARMONY BIOSCIENCES LLC
$49
Allergan, Inc.
$47
Shire North American Group Inc
$42
Harmony Biosciences LLC
$35
Alfasigma USA, Inc.
$31
Tris Pharma Inc
$31
Neuronetics, Inc.
$22
Noven Therapeutics, LLC
$20
Almatica Pharma LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Genentech, Inc.
$14
Kaleo, Inc.
$14
Titan Pharmaceuticals, Inc.
$12
Biohaven Pharmaceutical Holding Company Ltd.
$12
GE HEALTHCARE
$3
Top 3 companies account for 59.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADLARITY · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Aimovig · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BOTOX · BRINTELLIX · CAPLYTA · CITALOPRAM · COBENFY · Dayvigo · Dyanavel XR · Evzio · FANAPT · Fanapt · Fycompa · HETLIOZ · HORIZANT · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · IonicRF Generator · LATUDA · LONHALA MAGNAIR · LYBALVI · Lucemyra/Lofexidine · NEUROSTAR TMS THERAPY · NUEDEXTA · NUPLAZID · NURTEC ODT · None · Nuedexta · OCTRODE · Probuphine · QUVIVIQ · Qelbree · REJOYN · REXULTI · SABRIL · SPRAVATO · SUBLOCADE · SUNOSI · Sunosi · TRINTELLIX · UBRELVY · UPLIZNA · UZEDY · VIIBRYD · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VNS Therapy Symmetry Model 8103 Generator · VRAYLAR · VYVANSE · Vivitrol · WAKIX · WELLBUTRIN · XYWAV · Xelstrym · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Psychiatrists in nearby ZIP areas
158
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Capote is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Capote experienced with assessment of emotional or behavioral problems?
Based on Medicare claims data, Dr. Capote performed 222 assessment of emotional or behavioral problems services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Capote receive payments from pharmaceutical companies?
Yes. Dr. Capote received a total of $990,973 from 56 companies across 2,398 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Capote's costs compare to other psychiatrists in Amherst?
Dr. Capote's average Medicare payment per service is $221. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Capote) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Psychiatrists in Amherst
Browse psychiatrists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in NY
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in NY
Which NY psychiatrists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology